TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9005975

Group type: EXPERIMENTAL
Intervention: Hexarelin (HEX) 2 microg/kg IV
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Hexarelin (HEX) combined with GHRH (2 microg/kg IV)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Recombinant human GH (rhGH) 2 U IV
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Hexarelin (HEX) combined with pyridostigmine (PD) 120 mg orally
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Hexarelin (HEX) combined with GHRH and PD
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Hexarelin (HEX) combined with GHRH
Number of subjects: 6
Study: 8504051

Group type: EXPERIMENTAL
Intervention: 15 micrograms/g calcitriol ointment applied twice daily
Number of subjects: 32

Group type: COMPARATOR
Intervention: Vehicle ointment
Number of subjects: 32
Study: 3123600

Group type: EXPERIMENTAL
Intervention: R-(-)-deprenyl
Number of subjects: 30

Group type: COMPARATOR
Intervention: methixene
Number of subjects: 30
Study: 29479099

Group type: EXPERIMENTAL
Intervention: Routine periodontal treatment methods for streptococcal gingivitis
Number of subjects: 16

Group type: COMPARATOR
Intervention: Supportive treatment with antacid chewing tablet two times a day for a week
Number of subjects: 16
Study: 26494831

Group type: EXPERIMENTAL
Intervention: GSK1278863 (0.5 mg, 2 mg, or 5 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GSK1278863 (5 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Recombinant human erythropoietin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GSK1278863
Number of subjects: 0
Study: 24788501

Group type: EXPERIMENTAL
Intervention: Targon Femoral Neck (TFN) hip screw
Number of subjects: 174

Group type: COMPARATOR
Intervention: Cannulated screw fixation
Number of subjects: 174
Study: 23024236

Group type: EXPERIMENTAL
Intervention: Regulated individualized suction (range: -11 to -20 cmH2O)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Regulated seal (-2 cmH2O)
Number of subjects: 100
Study: 20334692

Group type: EXPERIMENTAL
Intervention: Progressive resistance training
Number of subjects: 70

Group type: COMPARATOR
Intervention: Arts/social programme
Number of subjects: 70
Study: 18982209

Group type: EXPERIMENTAL
Intervention: Chlorhexidine
Number of subjects: 8
Study: 16352688

Group type: EXPERIMENTAL
Intervention: Quinapril 20 mg daily for 2 months
Number of subjects: 24
Study: 15004772

Group type: EXPERIMENTAL
Intervention: Conventional VVB
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Piggyback LT
Number of subjects: 67
Study: 10646878

Group type: EXPERIMENTAL
Intervention: Flutamide (FLU)
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Cyproterone acetate (CPA)
Number of subjects: 310
Study: 9058444

Group type: EXPERIMENTAL
Intervention: Standard PPN Group (SG, n = 19)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Modified Group (MG, n = 22)
Number of subjects: 41
Study: 8436149

Group type: EXPERIMENTAL
Intervention: Bisoprolol 2.5 mg per day
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Bisoprolol 5 mg per day
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 2936370

Group type: EXPERIMENTAL
Intervention: Nebulized salbutamol (10 mg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Nebulized salbutamol (0.6 mg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Nebulized ipratropium bromide
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Combination of nebulized salbutamol and ipratropium bromide
Number of subjects: 20
Study: 31627965

Group type: EXPERIMENTAL
Intervention: Stretching with mobilization (SWM)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Stretching alone
Number of subjects: 40
Study: 30355358

Group type: EXPERIMENTAL
Intervention: Store-and-forward teledermatology in GP practices
Number of subjects: 260

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 260
Study: 28008244

Group type: EXPERIMENTAL
Intervention: Indacaterol/glycopyrronium (IND/GLY) 110 μg/50 μg
Number of subjects: 1263

Group type: EXPERIMENTAL
Intervention: Indacaterol/glycopyrronium (IND/GLY)
Number of subjects: 1263

Group type: COMPARATOR
Intervention: Salmeterol/fluticasone (SFC) 50 μg/500 μg
Number of subjects: 1263
Study: 24916694

Group type: EXPERIMENTAL
Intervention: Fulvestrant
Number of subjects: 103

Group type: COMPARATOR
Intervention: Low-dose Fulvestrant
Number of subjects: 103
Study: 22864943

Group type: COMPARATOR
Intervention: Curettage adenoidectomy (CA)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Transoral power‐assisted endoscopic adenoidectomy (PAEA)
Number of subjects: 53
Study: 20397858

Group type: EXPERIMENTAL
Intervention: Hold-Relax (HR) stretching technique
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Hold-Relax-Antagonist Contraction (HR-AC) stretching technique
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: EMG activation after HR-AC procedure
Number of subjects: 35
Study: 18498909

Group type: EXPERIMENTAL
Intervention: Combination therapy with olmesartan medoxomil (OM) and amlodipine besylate (AML)
Number of subjects: 1940

Group type: EXPERIMENTAL
Intervention: Combination therapy with OM and AML
Number of subjects: 1940

Group type: COMPARATOR
Intervention: Olmesartan medoxomil (OM) monotherapy
Number of subjects: 1940

Group type: COMPARATOR
Intervention: Amlodipine besylate (AML) monotherapy
Number of subjects: 1940

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1940

Group type: EXPERIMENTAL
Intervention: Combination therapy with OM/AML 20/10 mg and 40/10 mg
Number of subjects: 1940
Study: 15660633

Group type: EXPERIMENTAL
Intervention: Cognitive Interview (CI) for children who watched a film about a fakir (n=19)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Cognitive Interview (CI) for children who made up a story about a fakir (n=21)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Structured Interview (SI) for children who made up a story about a fakir (n=18)
Number of subjects: 58
Study: 12526069

Group type: EXPERIMENTAL
Intervention: Azithromycin 10 mg/kg/day for 3 days
Number of subjects: 110

Group type: COMPARATOR
Intervention: Erythromycin 50 mg/kg/day for 14 days
Number of subjects: 110

Group type: COMPARATOR
Intervention: Amoxicillin 75 mg/kg/day for 7 days
Number of subjects: 110
Study: 10536434

Group type: EXPERIMENTAL
Intervention: Terbinafine 1% topical solution for 1 week
Number of subjects: 429

Group type: COMPARATOR
Intervention: Clotrimazole 1% topical solution for 4 weeks
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: Terbinafine 1% solution (subgroup without protocol violation)
Number of subjects: 429

Group type: COMPARATOR
Intervention: Clotrimazole 1% solution (subgroup without protocol violation)
Number of subjects: 429

Group type: EXPERIMENTAL
Intervention: Terbinafine group
Number of subjects: 429

Group type: COMPARATOR
Intervention: Clotrimazole group
Number of subjects: 429
Study: 8871416

Group type: EXPERIMENTAL
Intervention: Behavior therapy plus the nicotine patch (BTP)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Behavior therapy alone (BT)
Number of subjects: 64
Study: 1649867

Group type: EXPERIMENTAL
Intervention: Oral potassium supplements
Number of subjects: 586
Study: 6366132

Group type: EXPERIMENTAL
Intervention: Simultaneous therapy (MTX 200 mg/m2 IV and 5-FU 600 mg/m2 IV)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Sequential therapy (MTX 200 mg/m2 IV followed by 5-FU 600 mg/m2 IV after one hour)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Simultaneous therapy (MTX 200 mg/m2 IV and 5-FU 600 mg/m2 IV) among stage III patients
Number of subjects: 79

Group type: COMPARATOR
Intervention: Sequential therapy (MTX 200 mg/m2 IV followed by 5-FU 600 mg/m2 IV after one hour) among stage III patients
Number of subjects: 79
Study: 31529590

Group type: EXPERIMENTAL
Intervention: JNJ-9375 (0.3 to 1.8 mg/kg)
Number of subjects: 308

Group type: COMPARATOR
Intervention: Apixaban (2.5 mg twice daily)
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: JNJ-9375
Number of subjects: 308

Group type: COMPARATOR
Intervention: Apixaban
Number of subjects: 308
Study: 29768313

Group type: EXPERIMENTAL
Intervention: Prasugrel (60 mg orally)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Clopidogrel (600 mg orally)
Number of subjects: 88
Study: 26950829

Group type: EXPERIMENTAL
Intervention: Vildagliptin 50 mg twice daily (BID)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Saxagliptin 5 mg once daily (QD)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Vildagliptin
Number of subjects: 73

Group type: COMPARATOR
Intervention: Saxagliptin
Number of subjects: 73
Study: 24502911

Group type: EXPERIMENTAL
Intervention: 2D virtual reality‐based program, six sessions of virtual game
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified intervention)
Number of subjects: 0
Study: 22094124

Group type: EXPERIMENTAL
Intervention: Biperiden
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 21702254

Group type: EXPERIMENTAL
Intervention: 0.15 mg/kg midazolam as pre‐medication 1 hour preoperatively
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo as pre‐medication
Number of subjects: 60
Study: 17339813

Group type: EXPERIMENTAL
Intervention: Diet intervention, frequency 3 to 5 times per week, duration 45 to 60 minutes, total period 12 to 24 weeks.
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Exercise intervention, frequency 3 to 5 times per week, duration 45 to 60 minutes, total period 12 to 24 weeks.
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Medication intervention, frequency 3 to 5 times per week, duration 45 to 60 minutes, total period 12 to 24 weeks.
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Lifestyle modification intervention, frequency 3 to 5 times per week, duration 45 to 60 minutes, total period 12 to 24 weeks.
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group not specified.
Number of subjects: 16
Study: 16382062

Group type: EXPERIMENTAL
Intervention: Rescue PCI
Number of subjects: 427

Group type: COMPARATOR
Intervention: Conservative therapy
Number of subjects: 427

Group type: COMPARATOR
Intervention: Repeated thrombolysis
Number of subjects: 427

Group type: COMPARATOR
Intervention: Repeated thrombolysis vs Conservative therapy
Number of subjects: 427

Group type: EXPERIMENTAL
Intervention: Rescue PCI vs Repeated thrombolysis
Number of subjects: 427

Group type: EXPERIMENTAL
Intervention: Rescue PCI vs Conservative therapy
Number of subjects: 427
Study: 12073949

Group type: EXPERIMENTAL
Intervention: External jugular venous pressure
Number of subjects: 20

Group type: COMPARATOR
Intervention: Central venous pressure
Number of subjects: 20
Study: 9856539

Group type: EXPERIMENTAL
Intervention: Drinking milk (300 ml)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Drinking water (300 ml)
Number of subjects: 27

Group type: COMPARATOR
Intervention: No drink (control)
Number of subjects: 27
Study: 7796718

Group type: EXPERIMENTAL
Intervention: Current users of anabolic steroids
Number of subjects: 46

Group type: COMPARATOR
Intervention: Former users of anabolic steroids
Number of subjects: 46

Group type: COMPARATOR
Intervention: Non-users of anabolic steroids
Number of subjects: 46
Study: 2131953

Group type: COMPARATOR
Intervention: Alginate-antacid (1 tablet to be chewed 30 min after each meal and at bed time)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Famotidine (1 mg/kg before supper at 7 pm)
Number of subjects: 49
Study: 374847

Group type: EXPERIMENTAL
Intervention: Novel pilocarpin polymeric salt eye drops
Number of subjects: 30

Group type: COMPARATOR
Intervention: Commercial aqueous pilocarpin solution
Number of subjects: 30
Study: 30614850

Group type: EXPERIMENTAL
Intervention: Hyoscine 0.3 mg
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 27557443

Group type: EXPERIMENTAL
Intervention: Biofeedback treatment (8-11 sessions of Electromyography biofeedback, Vasoconstriction-/Vasodilatation training, or a combination)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Biofeedback treatment
Number of subjects: 18
Study: 25942459

Group type: EXPERIMENTAL
Intervention: cART with tenofovir/emtricitabine plus ritonavir-boosted atazanavir
Number of subjects: 48
Study: 25033901

Group type: EXPERIMENTAL
Intervention: Motorized injector (group II)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Manual injector (group I)
Number of subjects: 62
Study: 22224655

Group type: COMPARATOR
Intervention: Curcumin (L-D+)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (L+D+)
Number of subjects: 13
Study: 19155765

Group type: EXPERIMENTAL
Intervention: Carotid artery stenting
Number of subjects: 0

Group type: COMPARATOR
Intervention: Carotid endarterectomy
Number of subjects: 0
Study: 17706718

Group type: EXPERIMENTAL
Intervention: Detrusor injection of 100 U botulinum toxin type A
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Suburothelial injection of 100 U botulinum toxin type A
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Bladder base injection of 100 U botulinum toxin type A
Number of subjects: 45
Study: 15837759

Group type: EXPERIMENTAL
Intervention: Cystatin C
Number of subjects: 59

Group type: COMPARATOR
Intervention: Serum creatinine
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Ideal body weight (IBW)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Cystatin C level
Number of subjects: 59
Study: 11782988

Group type: EXPERIMENTAL
Intervention: Focal dystonia patients
Number of subjects: 7

Group type: COMPARATOR
Intervention: Normal control subjects
Number of subjects: 7
Study: 9839106

Group type: EXPERIMENTAL
Intervention: Troglitazone (400 mg/day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Metformin (500 mg/day)
Number of subjects: 30
Study: 7988584

Group type: EXPERIMENTAL
Intervention: Laryngeal mask airway
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Nasal mask with nasopharyngeal airway
Number of subjects: 90

Group type: COMPARATOR
Intervention: Nasal mask alone
Number of subjects: 90
Study: 2724028

Group type: EXPERIMENTAL
Intervention: 0.075% sanguinaria-0.05% zinc chloride dentifrice
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: 0.24% sodium fluoride dentifrice
Number of subjects: 59

Group type: COMPARATOR
Intervention: 0.05% NaF solution (control)
Number of subjects: 59
Study: 31625761

Group type: EXPERIMENTAL
Intervention: Access to parks
Number of subjects: 978

Group type: EXPERIMENTAL
Intervention: Length of park stay
Number of subjects: 978

Group type: EXPERIMENTAL
Intervention: Level of physical activity
Number of subjects: 978

Group type: EXPERIMENTAL
Intervention: Park access
Number of subjects: 978

Group type: EXPERIMENTAL
Intervention: Cardiovascular diseases
Number of subjects: 978

Group type: EXPERIMENTAL
Intervention: Hypertension
Number of subjects: 978
Study: 29124991

Group type: EXPERIMENTAL
Intervention: Oral appliance treatment
Number of subjects: 65
Study: 27114587

Group type: EXPERIMENTAL
Intervention: High-dose methotrexate during interim maintenance 1
Number of subjects: 3154

Group type: EXPERIMENTAL
Intervention: High-dose methotrexate
Number of subjects: 3154

Group type: EXPERIMENTAL
Intervention: Dexamethasone and high-dose methotrexate
Number of subjects: 3154

Group type: COMPARATOR
Intervention: Dexamethasone during induction
Number of subjects: 3154
Study: 24533385

Group type: EXPERIMENTAL
Intervention: Mastoid obliteration with cartilage, bone dust, hydroxyapetite, and Singapore swing
Number of subjects: 40

Group type: COMPARATOR
Intervention: Open mastoid cavity (control group)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Mastoid obliteration with bone dust and Singapore swing
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Mastoid obliteration with cartilage and hydroxyapetite
Number of subjects: 40
Study: 23535292

Group type: EXPERIMENTAL
Intervention: 100 mg bid BDP + RTV for 28 days
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 600/100 mg bid BDP + DRV/r for 28 days
Number of subjects: 30

Group type: COMPARATOR
Intervention: BDP alone for 28 days (Control)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 30
Study: 19853533

Group type: EXPERIMENTAL
Intervention: I-125 brachytherapy alone (144 Gy)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: I-125 brachytherapy as a boost after 45-Gy EBRT (108 Gy)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: EBRT with rV(100%) >= 0.05 cc
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: EBRT with rV(100%) < 0.05 cc
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: EBRT with dose to hottest 0.1 cc
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: EBRT with dose to hottest 1%
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: EBRT with dose to hottest 3%
Number of subjects: 110
Study: 18212693

Group type: COMPARATOR
Intervention: Group corticosteroid (Group S) received 6-methylprednisolone 15 mg/kg IV 60 min before induction.
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Group TEA+corticosteroid (Group TEA+S) received 20 mg bupivacaine in bolus 60 min before induction followed by 20 mg/h bupivacaine infusion intraoperatively and postoperatively via epidural catheter.
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Group TEA (Group TEA) received 20 mg bupivacaine in bolus 60 min before induction followed by 20 mg/h bupivacaine infusion intraoperatively and postoperatively via epidural catheter.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Group control (Group C) received neither preinduction TEA nor a preinduction steroid.
Number of subjects: 60
Study: 17212187

Group type: EXPERIMENTAL
Intervention: Early psychological interventions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Current early psychological interventions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomised controlled studies
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transfer of intervention strategies from adults
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Consideration of developmental aspects
Number of subjects: 0
Study: 14672294

Group type: EXPERIMENTAL
Intervention: Meat
Number of subjects: 554

Group type: EXPERIMENTAL
Intervention: Milk
Number of subjects: 554

Group type: EXPERIMENTAL
Intervention: Energy
Number of subjects: 554

Group type: COMPARATOR
Intervention: Control
Number of subjects: 554
Study: 11164205

Group type: EXPERIMENTAL
Intervention: Dry powder of mannitol
Number of subjects: 2
Study: 9128319

Group type: EXPERIMENTAL
Intervention: MISO TID (200 microg three times daily)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: MISO BID (200 microg two times daily)
Number of subjects: 70

Group type: COMPARATOR
Intervention: RAN (150 mg twice daily)
Number of subjects: 70
Study: 7949692

Group type: EXPERIMENTAL
Intervention: heliotropin with humidified air (n = 20)
Number of subjects: 57

Group type: COMPARATOR
Intervention: humidified air alone (n = 37)
Number of subjects: 57
Study: 3622786

Group type: EXPERIMENTAL
Intervention: Betadine in the Foley drainage bag
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group (no Betadine)
Number of subjects: 56
Study: 29742273

Group type: EXPERIMENTAL
Intervention: Educational manual for childbirth companions
Number of subjects: 65
Study: 28131706

Group type: EXPERIMENTAL
Intervention: Device-managed automatic therapy for atrial tachycardia or fibrillation (AT/AF)
Number of subjects: 420

Group type: COMPARATOR
Intervention: In-hospital approach for treatment of symptomatic AT/AF
Number of subjects: 420
Study: 26780278

Group type: EXPERIMENTAL
Intervention: 1000 IU vitamin D3
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 1000 IU vitamin D3 plus 500 mg calcium
Number of subjects: 90

Group type: COMPARATOR
Intervention: Plain yogurt drink (control group)
Number of subjects: 90
Study: 23278367

Group type: EXPERIMENTAL
Intervention: Single dose of tenofovir dipivoxil fumarate 150 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single dose of tenofovir dipivoxil fumarate 300 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single dose of tenofovir dipivoxil fumarate 600 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multiple doses of tenofovir dipivoxil fumarate 300 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single dose of tenofovir dipivoxil fumarate 300 mg with high-fat meal
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single dose of tenofovir dipivoxil fumarate 300 mg fasting vs multiple doses
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single dose of tenofovir dipivoxil fumarate 300 mg with food
Number of subjects: 0
Study: 21843215

Group type: EXPERIMENTAL
Intervention: Ketamine/propofol (ketofol)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Midazolam/fentanyl (MF)
Number of subjects: 62
Study: 18283141

Group type: EXPERIMENTAL
Intervention: E-mail communication (group E)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard information sheet (group S)
Number of subjects: 100
Study: 16449518

Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Adenosine
Number of subjects: 150

Group type: COMPARATOR
Intervention: Normal Saline
Number of subjects: 150
Study: 14739493

Group type: EXPERIMENTAL
Intervention: Fine-needle nonaspiration (FNNA) technique
Number of subjects: 200

Group type: COMPARATOR
Intervention: Fine-needle aspiration (FNA) technique
Number of subjects: 200
Study: 10832669

Group type: EXPERIMENTAL
Intervention: Ribavirin (Rb) 1200 mg/day
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (Pl)
Number of subjects: 60
Study: 9334613

Group type: EXPERIMENTAL
Intervention: Lower energy transurethral microwave thermotherapy (Prostasoft 2.0)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 50
Study: 30362389

Group type: EXPERIMENTAL
Intervention: Gene‐Eden‐VIR/Novirin
Number of subjects: 68

Group type: COMPARATOR
Intervention: Acyclovir and Valacyclovir
Number of subjects: 68
Study: 27287818

Group type: EXPERIMENTAL
Intervention: Standardized perioperative behavioral/pelvic floor exercise intervention plus midurethral sling
Number of subjects: 433

Group type: COMPARATOR
Intervention: Midurethral sling alone
Number of subjects: 433
Study: 24977293

Group type: EXPERIMENTAL
Intervention: Sublingual ketamine wafer (25 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Intravenous ketamine (10 mg)
Number of subjects: 8
Study: 22731800

Group type: EXPERIMENTAL
Intervention: Midazolam and 25 mg of meperidine
Number of subjects: 120

Group type: COMPARATOR
Intervention: Midazolam and 20 mg of hyoscine N‐butylbromide
Number of subjects: 120
Study: 19860965

Group type: EXPERIMENTAL
Intervention: Day Program activities
Number of subjects: 132